Joel F.  Dube net worth and biography

Joel Dube Biography and Net Worth

CAO of Vapotherm
Currently, Joel F. Dube holds the position of Chief Accounting Officer & Vice President at Exa Corp.

In the past Mr. Dube was Chief Accounting Officer of Vapotherm, Inc.

Mr. Dube received an undergraduate degree from the University of Lowell.

How do I contact Joel F. Dube?

The corporate mailing address for Mr. Dube and other Vapotherm executives is 100 DOMAIN DRIVE, EXETER NH, 03833. Vapotherm can also be reached via phone at (866) 410-9986 and via email at [email protected]. Learn More on Joel F. Dube's contact information.

Has Joel F. Dube been buying or selling shares of Vapotherm?

Joel F. Dube has not been actively trading shares of Vapotherm during the last ninety days. Most recently, Joel F. Dube sold 124 shares of the business's stock in a transaction on Friday, September 10th. The shares were sold at an average price of $232.80, for a transaction totalling $28,867.20. Learn More on Joel F. Dube's trading history.

Who are Vapotherm's active insiders?

Vapotherm's insider roster includes Joel Dube (CAO), John Landry (CFO), James Liken (Director), Gregoire Ramade (SVP), and Thomas Smith (Insider). Learn More on Vapotherm's active insiders.

Joel F. Dube Insider Trading History at Vapotherm

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2021Sell124$232.80$28,867.20View SEC Filing Icon  
See Full Table

Joel F. Dube Buying and Selling Activity at Vapotherm

This chart shows Joel F Dube's buying and selling at Vapotherm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vapotherm Company Overview

Vapotherm logo
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Read More

Today's Range

Now: $2.17
Low: $2.16
High: $2.17

50 Day Range

MA: $2.16
Low: $2.13
High: $2.18

2 Week Range

Now: $2.17
Low: $0.70
High: $3.44

Volume

51,500 shs

Average Volume

N/A

Market Capitalization

$13.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A